+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 380 Pages
  • Global
From
Metastatic Cancer Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • February 2026
  • 211 Pages
  • Global
From
Carcinoembryonic Antigen - Global Strategic Business Report - Product Thumbnail Image

Carcinoembryonic Antigen - Global Strategic Business Report

  • Report
  • February 2026
  • 485 Pages
  • Global
From
Peptide Drug Conjugates - Global Strategic Business Report - Product Thumbnail Image

Peptide Drug Conjugates - Global Strategic Business Report

  • Report
  • February 2026
  • 282 Pages
  • Global
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • February 2026
  • 291 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 126 Pages
  • Global
From
MEK Inhibitors - Global Strategic Business Report - Product Thumbnail Image

MEK Inhibitors - Global Strategic Business Report

  • Report
  • February 2026
  • 132 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 291 Pages
  • Global
From
From
From
Bortezomib Market - Global Strategic Business Report - Product Thumbnail Image

Bortezomib Market - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 193 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
From
From
Neuroendocrine Tumor Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumor Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 383 Pages
  • Global
From
Loading Indicator